Innovations in AI and Data at the Veeva Summit Transforming Agent Commerce

Transforming Agent Commerce Through AI at the Veeva Summit

The recent Veeva Summit, hosted in Copenhagen, brought together over 1,200 leading figures from the life sciences sector to discuss groundbreaking advances in artificial intelligence (AI) and data innovations. The event featured prominent executives from top pharmaceutical giants like AstraZeneca, Bristol Myers Squibb, Grünenthal, Novo, Roche, and UCB. Together, they shared strategies to enhance commercial and medical excellence within their organizations.

Understanding the Role of AI in Engagement

One of the primary focuses of the summit was the application of AI in improving customer engagement. Attendees learned how tailored AI solutions can empower sales and marketing teams, providing them with insights that enhance their connection with healthcare professionals (HCPs) and ultimately improve patient outcomes. Moreover, Veeva demonstrated how a blend of digital and in-person interactions can generate valuable commercial proof points that refine understanding of HCP and patient needs.

Key Topics Discussed

1. Automated Customer Engagement: Grünenthal and Roche shared their advancements in automated customer engagement strategies designed to create connected customer journeys across various platforms, including in-person and digital channels.

2. Optimized Content Approval: Bristol Myers Squibb highlighted their usage of automated Medical, Legal, and Regulatory (MLR) processes to accelerate the approval of promotional content, significantly enhancing team productivity.

3. Data-Driven Decision-Making: AstraZeneca showcased how they are leveraging healthcare access data to sharpen field targeting and promote sales growth. Bayer and Servier also discussed the establishment of a global database that enables broader AI deployment, facilitating improved decision-making across markets.

4. Patient Outcome Improvements: Biogen and UCB presented on how they are transforming medical knowledge into actionable insights aimed at enriching decision-making and ultimately improving patient results. The discussions encompassed how an increasing reliance on AI among healthcare professionals is reshaping scientific engagement strategies.

The Future of Interaction

Chris Moore, President of Veeva Europe, commented on the accelerated pace of innovation in life sciences, stating, "The emergence of AI opens new avenues for timely and relevant interactions with healthcare professionals and patients.” His insights echoed the necessity for constant adaptation as the industry trends toward more agentic business models.

The Veeva Summit served not just as a networking platform but as a crucial space for collaboration between companies seeking to thrive amid evolving market demands. This exchange of knowledge is pivotal as the life sciences landscape shifts toward smart technology integration.

Exclusive Participation

The event was exclusively tailored for professionals within the life sciences industry, emphasizing the importance of industry-specific insights. Veeva Systems continues to lead with its cloud platform designed specifically for life sciences, further supporting more than 1,500 clients, including some of the world’s top biopharmaceutical companies and emerging biotech firms. Veeva’s commitment to product excellence and innovation has positioned it as a vital player in this space.

As the summit concluded, it reinforced the notion that the future of agent commerce is inherently tied to embracing AI and data as critical components for success. For more information on Veeva Systems and their range of services, visit veeva.com/eu.